Catching and treating infectious disease states before they become established or chronic is important for the best patient outcome, but also has knock on effects on the efficiency of any practice or health care provider.
SureScreen's range of infectious disease screens equip you with a quick outcome allowing you to take swift action.
With a range of sample types, including whole blood, serum, plasma, urine and fecal sample, the range of these health screening devices is broad.
With high accuracy and ease of use, they should be part of any comprehensive health screening initiative as a first, efficient step in diagnosing and monitoring infectious disease states.
SureScreen’s COVID-19 rapid test identifies the body’s response to coronavirus 3-7 days after infection, and gives a qualitative yes/no result within 10 minutes.
* Parameters vary by test and may not all be available from the same product.